Development of highly sensitive Bicistronic vector based non-radioactive antigen-specific cytotoxicity assay
Pranav Gupta1, Ruchi Tayal, Hemlata Durgapal
1Department of Pathology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi-110029, India.
Journal of Immunological Methods
|August 18, 2009
Summary
This study introduces a novel, non-radioactive assay for measuring T-cell mediated cytotoxicity. The method uses bicistronic vectors to quantify target cell lysis, offering an easier alternative to traditional chromium-51 release assays.
Area of Science:
- Immunology
- Cellular Biology
- Biotechnology
Background:
- The chromium-51 (51Cr) release assay is the standard for detecting T-cell mediated cytotoxicity but has significant drawbacks.
- Limitations include radioactivity use, target cell pre-loading issues, and MHC restriction.
Purpose of the Study:
- To develop a novel, non-radioactive, and simplified method for assessing T-cell mediated cytotoxicity.
- To overcome the limitations of the conventional 51Cr release assay.
Main Methods:
- A bicistronic vector system was engineered to co-express a specific antigen (HBV core) and a reporter gene (EGFP/Fluc).
- Target cells were transfected with the bicistronic vector, and effector cells were generated from immunized mice.
- Cytolytic activity was measured by quantifying reporter gene expression in remaining viable target cells.
Main Results:
- The bicistronic vector system successfully expressed antigen and reporter genes in various cell lines.
- The assay demonstrated antigen-specific T-cell mediated cytotoxicity.
- Results correlated well with the conventional 51Cr release assay, validating the new method.
Conclusions:
- A novel, easy-to-perform, antigen-specific, and non-radioactive assay for T-cell mediated cytotoxicity was established.
- This bicistronic vector-based assay provides a viable alternative to radioactive methods for assessing cellular immune responses.
